Nasu-Hakola Disease (Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy-PLOSL): A Dementia Associated with Bone Cystic Lesions. From Clinical to Genetic and Molecular Aspects

Cellular and Molecular Neurobiology

Volumn 24, Issue 1, 2004, Pages 1-24

  Bianchin, Marino Muxfeldt ^a,b   Capella, Heraldo M ^b   Chaves, Daniel Loureiro ^b,c,d   Steindel, Mário ^e   Grisard, Edmundo C ^e   Ganev, Gerson Gandi ^b   Da Silva Jr , João Péricles ^e,f   Neto, Evaldo Schaeffer ^d,g   Poffo, Mônica Aparecida ^b   Walz, Roger ^a   Carlotti Jr , Carlos G ^a   Sakamoto, Américo C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Hosp Reg S Jose H de M Gomes   (Brazil)

^c Diagnostico Medico por Imagem DMI   (Brazil)

^d HOSPITAL GOVERNADOR CELSO RAMOS   (Brazil)

^e FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^f Lab de Anatomia Patologica Ltda AP   (Brazil)

^g SONITEC Diagnostico Por Imagem   (Brazil)

Author keywords

DAP12; Frontal dementia; Frontotemporal dementia; KARAP; Microglia; Osteoclasts; TREM2; TYROBP

Indexed keywords

RECEPTOR SUBUNIT;

BONE DYSPLASIA; CLINICAL FEATURE; DAP12 GENE; DEMENTIA; DISEASE ASSOCIATION; ELECTROPHYSIOLOGY; GENE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; LEUKOENCEPHALOPATHY; MEMBRANOUS LIPODYSTROPHY; MICROGLIA; NERVE DEGENERATION; NEUROIMAGING; OSTEOCLAST; PHENOTYPE; POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TREM2 GENE;

BONE DISEASES; DEMENTIA, VASCULAR; HUMANS; MEMBRANE GLYCOPROTEINS; MICROGLIA; MUTATION; OSTEOBLASTS; PHENOTYPE; RECEPTORS, IMMUNOLOGIC; SEQUENCE DELETION; SIGNAL TRANSDUCTION;

EID: 10744222733     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CEMN.0000012721.08168.ee     Document Type: Review

References (98)

1. Abrikossoff, A. (1929). Über das Schicksal der spontan auftretenden Fettgranulome (lipophagen Granulome). Verh. Dtsch. Ges. Pathol. 24:57-64.
2. Ahn, S., Yoo, M., Lee, S., and Choi, E. (1996). A clinical and histopathological study of 22 patients with membranous lipodystrophy. Clin. Exp. Dermatol. 21:269-272.
3. Akai, M., Tateishi, A., Cheng, C. H., Morii, K., Abe, M., Ohno, T., and Ben, M. (1977). Membranous lipodystrophy: A clinicopathological study of six cases. J. Bone Joint Surg. Am. 59:802-809.
4. Albright, A. V., Shieh, J. T., Itoh, T., Lee, B., Pleasure, D., O'Connor, M. J., Doms, R. W., and Gonzalez-Scarano, F. (1999). Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J. Virol. 73:205-213.
5. Amano, N., Iwabuchi, K., Sakai, H., Yagishita, S., Itoh, Y., Iseki, E., Yokoi, S., Arai, N., and Kinoshita, J. (1987). Nasu-Hakola's disease (membranous lipodystrophy). Acta Neuropathol. (Berl.) 74:294-299.
6. Araki, T., Ohba, H., Monzawa, S., Sakuyama, K., Hachiya, J., Seki, T., Takahashi, Y., and Yamaguchi, M. (1991). Membranous lipodystrophy: MR imaging appearance of the brain. Radiology 180:793-797.
7. Bacon, K. B., and Harrison, J. K. (2000). Chemokines and their receptors in neurobiology: Perspectives in physiology and homeostasis. J. Neuroimmunol. 104:92-97.
8. Bakker, A. B., Baker, E., Sutherland, G. R., Phillips, J. H., and Lanier, L. L. (1999). Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc. Natl. Acad. Sci. U.S.A. 96:9792-9796.
9. Bakker, A. B., Hoek, R. M., Cerwenka, A., Blom, B., Lucian, L., McNeil, T., Murray, R., Phillips, L. H., Sedgwick, J. D., and Lanier, L. L. (2000). DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13:345-353.
10. Banchereau, J., and Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature. 19:245-252.
11. Bird, T. D., Koerker, R. M., Leaird, B. J., Vlcek, B. W., and Thorning, D. R. (1983). Lipomembranous polycystic osteodysplasia (brain, bone, and fat disease): A genetic cause of presenile dementia. Neurology 33:81-86.
12. Blair, H. C. (1998). How the osteoclast degrades bone. Bioessays 20:837-846.
13. Blair, H. C., Zaidi, M., and Schlesinger, P. H. (2002). Mechanisms balancing skeletal matrix synthesis and degradation. Biochem. J. 364:329-341.
14. Bouchon, A., Dietrich, J., and Colonna, M. (2000). Cutting edge: Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J. Immunol. 164:4991-4995.
15. Bouchon, A., Hernandez-Munain, C., Cella, M., and Colonna, M. (2001). A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J. Exp. Med. 194:1111-1122.
16. Brown, D. R. (2001). Microglia and prion disease. Microsc. Res. Tech. 54:71-80.
17. Campbell, K. S., and Colonna, M. (1999). DAP12: A key accessory protein for relaying signals by natural killer cell receptors. Int. J. Biochem. Cell. Biol. 31:631-636.
18. Chabas, D., Baranzini, S. E., Mitchell, D., Bernard, C. C., Riitling, S. R., Denhardt, D. T., Sobel, R. A., Lock, C., Karpuj, M., Pedotti, R., Heller, R., Oksenberg, J. R., and Steinman, L. (2001). The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294:1731-1735.
19. Chung, D. H., Seaman, W. E., and Daws, M. R. (2002). Characterization of TREM-3, an activating receptor on mouse macrophages: Definition of a family of single Ig domain receptors on mouse chromosome 17. Eur. J. Immunol. 32:59-66.
20. Compston, J. E. (2002). Bone marrow and bone: A functional unit. J. Endocrinol. 173:387-394.
21. Coraci, I. S., Husemann, J., Berman, J. W., Hulette, C., Dufour, J. H., Campanella, G. K., Luster, A. D., Silverstein, S. C., and El-Khoury, J. B. (2002). CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am. J. Pathol. 160:101-112.
22. Cummings, J. L. (1986). Subcortical dementia. Neuropsychology, neuropsychiatry, and pathophysiology. Br. J. Psychiatry 149:682-697.
23. Diefenbach, A., Tomasello, E., Lucas, M., Jamieson, A. M., Hsia, J. K., Vivier, E., and Raulet, D. H. (2002). Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat. Immunol. 3:1142-1149.
24. Deisenhammer, F., Willeit, J., Schmidauer, C., Kiechl, S., and Pohl, P. (1993). [Membranous lipodystrophy (Nasu-Hakola disease)]. Nervenarzt. 64:263-265.
25. Dietrich, J., Cella, M., Seiffert, M., Buhring, H. J., and Colonna, M. (2000). Cutting edge: Signal-regulatory protein beta 1 is a DAP12-associated activating receptor expressed in myeloid cells. J. Immunol. 164:9-12.
26. Ducy, P., Schinke, T., and Karsenty, G. (2000). The osteoblast: A sophisticated fibroblast under central surveillance. Science 289:1501-1504.
27. Duong, L. T., and Rodan, G. A. (2001). Regulation of osteoclast formation and function. Ver. Endocr. Metab. Disord. 2:95-104.
28. Gallucci, S., Lolkema, M., and Matzinger, P. (1999). Natural adjuvants: Endogeneous activators of dendritic cells. Nat. Med. 11:1249-1255.
29. Gebicke-Haerter, P. J. (2001). Microglia in neurodegeneration: Molecular aspects. Microsc. Res. Tech. 54:47-58.
30. Gebicke-Haerter, P. J., Spleiss, O., Ren, L. Q., Li, H., Dichmann, S., Norgauer, J., and Boddeke, H. W. (2001). Microglial chemokines and chemokine receptors. Prog. Brain Res. 132:525-532.
31. Gebicke-Haerter, P. J., Van Calker, D., Norenberg, W., and Illes, P. (1996). Molecular mechanisms of microglial activation. A. Implications for regeneration and neurodegenerative diseases. Neurochem. Int. 29:1-12.
32. Gilfillan, S., Ho, E. L., Cella, M., Yokoyama, W. M., and Colonna, M. (2002). NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat. Immunol. 3:1150-1155.
33. Gonzalez-Scarano, F., and Baltuch, G. (1999). Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22:219-240.
34. Greenfield, E. M., Bi, Y., and Miyauchi, A. (1999). Regulation of osteoclast activity. Life Sci. 65:1087-1102.
35. Hakola, H. P. (1972). Neuropsychiatric and genetic aspects of a new hereditary disease characterized by progressive dementia and lipomembranous polycystic osteodysplasia. Acta Psychiatr. Scand. Suppl. 232:1-173.
36. Hakola, H. P., and Karjalanen, P. (1975). Bone mineral content in hereditary polycystic osteodysplasia associated with progressive dementia. Acta. Radiol. Diagn. 16:385-392.
37. Hakola, H. P. (1998). Benton's Visual Retention Test in patients with polycystic lipomembranous dysplasia with sclerosing leukoencephalopathy. Dement. Geriatr. Cogn. Disord. 9:39-43.
38. Hakola, H. P., Jarvi, O. H., and Sourander, P. (1970). Osteodysplasia polycystica hereditaria combined with sclerosing leucoencephalopathy, a new entity of the dementia praesenilis group. Acta Neurol. Scand. 46(Suppl 43):79.
39. Hakola, H. P., Karjalainen, P., and Virtama, P. (1988). Bone scintigraphy in polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy. Nucl. Med. Commun. 9:1005-1011.
40. Hakola, H. P., and Partanen, V. S. (1983). Neurophysiological findings in the hereditary presenile dementia characterised by polycystic lipomembranous osteodysplasia and sclerosing leukoencephalopathy. J. Neurol. Neurosurg. Psychiatry 46:515-520.
41. Hakola, H. P., and Puranen, M. (1993). Neuropsychiatric and brain CT findings in polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy. Acta Neurol. Scand. 88:370-375.
42. Halliday, G., Robinson, S. R., Shepherd, C., and Kril, J. (2000). Alzheimer's disease and inflammation: A review of cellular and therapeutic mechanisms. Clin. Exp. Pharmacol. Physiol. 27:1-8.
43. Harada, K. (1975). [A case of "membranous lipodystrophy (Nasu) " with emphasis on psychiatric and neuropathologic aspects (Author's Transl.)]. Folia Psychiatr. Neurol. Jpn. 29:169-177.
44. Hasegawa, Y., and Inagaki, Y. (1983). Membranous lipodystrophy (lipomembranous polycystic osteodysplasia). Two case reports. Clin. Orthop. 12:229-232.
45. Hill, P. A. (1998). Bone remodelling. Br. J. Orthod. 25:101-107.
46. Hull, M., Lieb, K., and Fiebich, B. L. (2002). Pathways of inflammatory activation in Alzheimer's disease: Potential targets for disease modifying drugs. Curr. Med. Chem. 9:83-88.
47. Kalimo, H., Sourander, P., Jarvi, O., and Hakola, P. (1994). Vascular changes and blood-brain barrier damage in the pathogenesis of polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (membranous lipodystrophy). Acta Neurol. Scand. 89:353-361.
48. Kaul, M., Garden, G. A., and Lipton, S. A. (2001). Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988-994.
49. Kaul, M., and Lipton, S. A. (1999). Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. U.S.A. 96:8212-8216.
50. Kenny, A. M., and Raisz, L. G. (2002). Mechanisms of bone remodeling: Implications for clinical practice. J. Reprod. Med. 47:63-70.
51. Kitajima, I., Kuriyama, M., Usuki, F., Izumo, S., Osame, M., Suganuma, T., Murata, F., and Nagamatsu, K. (1989). Nasu-Hakola disease (membranous lipodystrophy). Clinical, histopathological and biochemical studies of three cases. J. Neurol. Sci. 91:35-52.
52. Kocer, N., Dervisoglu, S., Ersavasti, G., Altug, A., and Cokyuksel, O. (1994). Case report 867. Membranous lipodystrophy (polycystic lipomembranous osteodysplasia). Skeletal Radiol 23:577-579.
53. Kondo, T., Takahashi, K., Kohara, N., Takahashi, Y., Hayashi, S., Takahashi, H., Matsuo, H., Yamazaki, M., Inoue, K., Miyamoto, K., and Yamamura, T. (2002). Heterogeneity of presenile dementia with bone cysts (Nasu-Hakola disease). Three genetic forms. Neurology 59:1105-1107.
54. Langford, D., and Masliah, E. (2001). Crosstalk between components of the blood brain barrier and cells of the CNS in microglial activation in AIDS. Brain Pathol. 11:306-312.
55. Lanier, L. L. (1998). NK cell receptors. Annu. Rev. Immunol. 16:359-393.
56. Lanier, L. L., and Bakker, A. B. (2000). The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function. Immunol. Today 21:611-614.
57. Lanier, L. L., Corliss, B., Wu, J., and Phillips, J. H. (1998a). Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 8:693-701.
58. Lanier, L. L., Corliss, B. C., Wu, J., Leong, C., and Phillips, J. H. (1998b). Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature. 391:703-707.
59. Machinami, R. (1984). Incidence of membranous lipodystrophy-like change among patients with limb necrosis caused by chronic arterial obstruction. Arch. Pathol. Lab. Med. 108:823-826.
60. Machinami, R. (2001). [Membranous lipodystrophy of the bone]. Ann. Pathol. 21:524-528.
61. Malandrini, A., Scarpini, C., Palmeri, S., Villanova, M., Parrotta, E., Tripodi, S., Giani, S., DeFalco, D., and Guazzi, G. C. (1996). Palatal myoclonus and unusual MRI findings in a patient with membranous lipodystrophy. Brain. Dev. 18:59-63.
62. Manolagas, S. C. (2000). Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21:115-137.
63. Matsushita, M., Oyanagi, S., Hanawa, S., Shiraki, H., and Kosaka, K. (1981). Nasu-Hakola's disease (membranous lipodystrophy). A case report. Acta Neuropathol. (Berl.) 54:89-93.
64. McVicar, D. W., Taylor, L. S., Gosselin, P., Willette-Brown, J., Mikhael, A. I., Geahlen, R. L., Nakamura, M. C., Linnemeyer, P., Seaman, W. E., Anderson, S. K., Ortaldo, J. R., and Mason, L. H. (1998). DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk proteintyrosine kinase. J. Biol. Chem. 273:32934-32942.
65. Merrill, J. E. (1992). Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. J. Immunother. 12:167-170.
66. Minagar, A., Shapshak, P., Fujimura, R., Ownby, R., Heyes, M., and Eisdorfer, C. (2002). The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J. Neurol. Sci. 202:13.
67. Mitrovic, B., Martin, F. C., Charles, A. C., Ignarro, L. J., Anton, P. A., Shanahan, F., and Merrill, J. E. (1994). Neurotransmitters and cytokines in CNS pathology. Prog. Brain. Res. 103:319-330.
68. Miyazu, K., Kobayashi, K., Fukutani, Y., Nakamura, I., Hasegawa, H., Yamaguchi, N., and Saitoh, T. (1991). Membranous lipodystrophy (Nasu-Hakola disease) with thalamic degeneration: Report of an autopsied case. Acta Neuropathol. (Berl.) 82:414-419.
69. Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., et al. (2001). Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Ver. Immunol. 19:197-223.
70. Motohashi, N., Shinohara, M., Shioe, K., Fukuzawa, H., Akiyama, Y., and Kariya, T. (1995). A case of membranous lipodystrophy (Nasu-Hakola disease) with unique MRI findings. Neuroradiology 37:549-550.
71. Nakamura, Y. (2002). Regulating factors for microglial activation. Biol. Pharm. Bull. 25:945-953.
72. Nasu, T., Tsukahara, Y., and Terayama, K. (1973). A lipid metabolic disease-"membranous lipodystrophy" - an autopsy case demonstrating numerous peculiar membrane-structures composed of compound lipid in bone and bone marrow and various adipose tissues. Acta Pathol. Jpn. 23:539-558.
73. Ohtani, Y., Miura, S., Tamai, Y., Kojima, H., and Kashima, H. (1979). Neutral lipid and sphingolipid composition of the brain of a patient with membranous lipodystrophy. J. Neurol. 220:77-82.
74. Okada, K., Hoshi, N., Kawamura, K., Sato, K., and Yamamoto, M. (1999). Membranocystic lesion in lumbar yellow ligament. Spine. 24:1147-1150.
75. Paloneva, J., Autti, T., Raininko, R., Partanen, J., Salonen, O., Puranen, M., Hakola, P., and Haltia, M. (2001). CNS manifestations of Nasu-Hakola disease: A frontal dementia with bone cysts. Neurology 56:1552-1558.
76. Paloneva, J., Kestila, M., Wu, J., Salminen, A., Bohling, T., Ruotsalainen, V., Hakola, P., Bakker, A. B., Phillips, J. H., Pekkarinen, P., Lanier, L. L., Timonen, T., and Peltonen, L. (2000). Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat. Genet. 25:357-361.
77. Paloneva, J., Manninen, T., Christman, G., Hovanes, K., Mandelin, J., Adolfsson, R., Bianchin, M., Bird, T., Miranda, R., Salmaggi, A., Tranebjaerg, L., Konttinen, Y., and Peltonen, L. (2002). Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am. J. Hum. Genet. 71:656-662.
78. Pazzaglia, U. E., Benazzo, F., Byers, P. D., Riboni, L., and Ceciliani, L. (1987). Pathogenesis of membranous lipodystrophy. Case report and review of the literature. Clin. Orthop. 279-287.
79. Pekkarinen, P., Hovatta, I., Hakola, P., Jarvi, O., Kestila, M., Lenkkeri, U., Adolfsson, R., Holmgren, G., Nylander, P. O., Tranebjaerg, L., Terwilliger, J. D., Lonnqvist, J., and Peltonen, L. (1998). Assignment of the locus for PLO-SL, a frontal-lobe dementia with bone cysts, to 19q13. Am. J. Hum. Genet. 62:362-372.
80. Preziuso, L., Muncibi, F., and Aglietti, F. G. (1992). A case of membranous lipodystrophy with skeletal involvement. Chir. Organi. Mov. 77:205-211.
81. Sageshima, M., Masuda, H., Kawamura, K., and Shozawa, T. (1987). Membranous lipodystrophy. Light and electron microscopic study of a biopsy case. Acta Pathol. Jpn. 37:281-290.
82. Sami, S., Liu, G., Hornicek, F., Cates, J. M., and Mankin, H. J. (2002). Membranous lipodystrophy. A case report. J. Bone Joint Surg. Am. 84-A:630-633.
83. Sauter, B., Albert, M. L., Francisco, L., Larson, M., Somersoon, S., and Bhardwaj, N. (2000). Consequences of cell death: Exposure to necrotic tumor cells, but not primary cells or apoptotic cells, introduces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191:411-416.
84. Schafer, C., Klunemann, H. H., Ibach, B., Mueller, J., Putzhammer, A., Trender-Gerhard, I., Schuierer, G., and Klein, H. E. (2002). [Presenile dementia in polycystic lipomembranous osteodysplasia]. Nervenarzt 73:879-882.
85. Sjolin, H., Tomasello, E., Mousavi-Jazi, M., Bartolazzi, A., Karre, K., Vivier, E., and Cerboni, C. (2002). Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J. Exp. Med. 195:825-834.
86. Smith, K. M., Wu, J., Bakker, A. B., Phillips, J. H., and Lanier, L. L. (1998). Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J. Immunol. 161:7-10.
87. Stubgen, J. P., and Lotz, B. P. (1992). Membranous lipodystrophy. Clinical and electrophysiological observations in the first South African case. S. Afr. Med. J. 81:620-622.
88. Tanaka, J. (1980). Leukoencephalopathic alteration in membranous lipodystrophy. Acta Neuropathol. (Berl.) 50:193-197.
89. Tanaka, J. (2000). Nasu-Hakola disease: A review of its leukoencephalopathic and membranolipodystrophic features. Neuropathology 20(Suppl):S25-S29.
90. Teitelbaum, S. L. (2000). Bone resorption by osteoclasts. Science 289:1504-1508.
91. Teitelbaum, S. L., Tondravi, M. M., and Ross, F. P. (1997). Osteoclasts, macrophages, and the molecular mechanisms of bone resorption. J. Leukoc. Biol. 61:381-388.
92. Tomasello, E., Desmoulins, P. O., Chemin, K., Guia, S., Cremer, H., Ortaldo, J., Love, P., Kaiserlian, D., and Vivier, E. (2000). Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. Immunity 13:355-364.
93. Tranebjaerg, L., Schrader, H., and Paloneva, J. (2000). [Polycystic lipomembranous osteodysplasia]. Tidsskr. Nor. Laegeforen. 120:3196.
94. Ueki, Y., Kohara, N., Oga, T., Fukuyama, H., Akiguchi, I., Kimura, J., and Shibasaki, H. (2000). Membranous lipodystrophy presenting with palilalia: A PET study of cerebral glucose metabolism. Acta Neurol. Scand. 102:60-64.
95. Vaananen, H. K., Zhao, H., Mulari, M., and Halleen, J. M. (2000). The cell biology of osteoclast function. J. Cell. Sci. 113(Pt. 3):377-381.
96. Van Everbroeck, B., Dewulf, E., Pals, P., Lubke, U., Martin, J. J., and Cras, P. (2002). The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease. Neurobiol. Aging. 23:59-64.
97. Verloes, A., Maquet, P., Sadzot, B., Vivario, M., Thiry, A., and Franck, G. (1997). Nasu-Hakola syndrome: Polycystic lipomembranous osteodysplasia with sclerosing leucoencephalopathy and presenile dementia. J. Med. Genet. 34:753-737.
98. Wood, C. (1978). Membranous lipodystrophy of bone. Arch. Pathol. Lab. Med. 102:22-27.